HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 08-DEC-04 1Y7I TITLE STRUCTURAL AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO SABP2 AS A TITLE 2 METHYLSALICYLATE ESTERASE AND FURTHER IMPLICATE IT IN PLANT INNATE TITLE 3 IMMUNITY, NORTHEAST STRUCTURAL GENOMICS TARGET AR2241 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SALICYLIC ACID-BINDING PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SABP2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NICOTIANA TABACUM; SOURCE 3 ORGANISM_COMMON: COMMON TOBACCO; SOURCE 4 ORGANISM_TAXID: 4097; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+MAGIC; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET21; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: BL21 KEYWDS ALPHA-BETA PROTEIN, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE KEYWDS 2 INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN KEYWDS 3 FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR F.FOROUHAR,Y.YANG,D.KUMAR,Y.CHEN,E.FRIDMAN,S.W.PARK,Y.CHIANG, AUTHOR 2 T.B.ACTON,G.T.MONTELIONE,E.PICHERSKY,D.F.KLESSIG,L.TONG,NORTHEAST AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 8 13-NOV-24 1Y7I 1 REMARK REVDAT 7 15-NOV-23 1Y7I 1 REMARK REVDAT 6 23-AUG-23 1Y7I 1 REMARK SEQADV LINK REVDAT 5 24-FEB-09 1Y7I 1 VERSN REVDAT 4 14-NOV-06 1Y7I 1 HEADER REVDAT 3 12-APR-05 1Y7I 1 JRNL REVDAT 2 22-FEB-05 1Y7I 1 JRNL REVDAT 1 21-DEC-04 1Y7I 0 JRNL AUTH F.FOROUHAR,Y.YANG,D.KUMAR,Y.CHEN,E.FRIDMAN,S.W.PARK, JRNL AUTH 2 Y.CHIANG,T.B.ACTON,G.T.MONTELIONE,E.PICHERSKY,D.F.KLESSIG, JRNL AUTH 3 L.TONG JRNL TITL STRUCTURAL AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO SABP2 AS JRNL TITL 2 A METHYL SALICYLATE ESTERASE AND IMPLICATE IT IN PLANT JRNL TITL 3 INNATE IMMUNITY JRNL REF PROC.NATL.ACAD.SCI.USA V. 102 1773 2005 JRNL REFN ISSN 0027-8424 JRNL PMID 15668381 JRNL DOI 10.1073/PNAS.0409227102 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 353462.510 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.9 REMARK 3 NUMBER OF REFLECTIONS : 31540 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3152 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3842 REMARK 3 BIN R VALUE (WORKING SET) : 0.2170 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 458 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4121 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 461 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.54000 REMARK 3 B22 (A**2) : 0.38000 REMARK 3 B33 (A**2) : 3.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.90000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 45.82 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Y7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1000031213. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97904 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34275 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 29.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.05700 REMARK 200 FOR THE DATA SET : 15.5100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.28100 REMARK 200 R SYM FOR SHELL (I) : 0.26100 REMARK 200 FOR SHELL : 3.470 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: COMO REMARK 200 STARTING MODEL: PDB ENTRY 1Y7H REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 10 MM SA, 0.2 M CALCIUM REMARK 280 ACETATE, 10 MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.61050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.01200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.61050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.01200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER. ALTHOUGH THE TWO MONOMERS IN ASU FORM A DIMER, THE REMARK 300 BIOCHEMICAL DATA SUGGEST THAT SABP2 ACTS AS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 LEU A 261 REMARK 465 GLU A 262 REMARK 465 HIS A 263 REMARK 465 HIS A 264 REMARK 465 HIS A 265 REMARK 465 HIS A 266 REMARK 465 HIS A 267 REMARK 465 HIS A 268 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 HIS B 265 REMARK 465 HIS B 266 REMARK 465 HIS B 267 REMARK 465 HIS B 268 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 14 -0.63 73.68 REMARK 500 SER A 81 -111.83 41.65 REMARK 500 ALA A 100 144.83 -176.45 REMARK 500 ALA A 105 47.35 39.52 REMARK 500 LEU A 132 -124.26 47.48 REMARK 500 TYR A 139 23.04 -145.05 REMARK 500 SER A 179 -157.20 -134.23 REMARK 500 LYS A 188 -3.97 -168.25 REMARK 500 LYS A 190 71.82 -114.27 REMARK 500 ARG A 196 -68.94 -96.62 REMARK 500 GLU A 244 54.39 -140.47 REMARK 500 CYS B 14 -1.02 72.64 REMARK 500 SER B 81 -112.60 44.18 REMARK 500 ALA B 105 51.42 36.58 REMARK 500 SER B 111 47.10 -104.64 REMARK 500 VAL B 112 -55.91 -132.00 REMARK 500 LEU B 132 -113.03 53.86 REMARK 500 TYR B 139 13.68 -148.00 REMARK 500 SER B 179 -154.82 -130.81 REMARK 500 ARG B 196 -72.13 -104.05 REMARK 500 ASN B 224 -73.86 -83.34 REMARK 500 HIS B 263 -76.17 -125.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAL B 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XKL RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH SALICYLIC ACID AND ISOTHIOCYANATE REMARK 900 RELATED ID: 1Y7H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO REMARK 900 SALICYLIC ACID BINDING PROTEIN 2 (SABP2) AS A METHYLSALICYLATE REMARK 900 ESTERASE AND FURTHER IMPLICATE IT IN PLANT DEFENSE REMARK 900 RELATED ID: AR2241 RELATED DB: TARGETDB DBREF 1Y7I A 1 260 UNP Q6RYA0 Q6RYA0_TOBAC 1 260 DBREF 1Y7I B 1 260 UNP Q6RYA0 Q6RYA0_TOBAC 1 260 SEQADV 1Y7I MSE A 63 UNP Q6RYA0 MET 63 MODIFIED RESIDUE SEQADV 1Y7I MSE A 66 UNP Q6RYA0 MET 66 MODIFIED RESIDUE SEQADV 1Y7I MSE A 85 UNP Q6RYA0 MET 85 MODIFIED RESIDUE SEQADV 1Y7I MSE A 91 UNP Q6RYA0 MET 91 MODIFIED RESIDUE SEQADV 1Y7I MSE A 108 UNP Q6RYA0 MET 108 MODIFIED RESIDUE SEQADV 1Y7I MSE A 149 UNP Q6RYA0 MET 149 MODIFIED RESIDUE SEQADV 1Y7I MSE A 183 UNP Q6RYA0 MET 183 MODIFIED RESIDUE SEQADV 1Y7I MSE A 239 UNP Q6RYA0 MET 239 MODIFIED RESIDUE SEQADV 1Y7I MSE A 241 UNP Q6RYA0 MET 241 MODIFIED RESIDUE SEQADV 1Y7I LEU A 261 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I GLU A 262 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS A 263 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS A 264 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS A 265 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS A 266 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS A 267 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS A 268 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I MSE B 63 UNP Q6RYA0 MET 63 MODIFIED RESIDUE SEQADV 1Y7I MSE B 66 UNP Q6RYA0 MET 66 MODIFIED RESIDUE SEQADV 1Y7I MSE B 85 UNP Q6RYA0 MET 85 MODIFIED RESIDUE SEQADV 1Y7I MSE B 91 UNP Q6RYA0 MET 91 MODIFIED RESIDUE SEQADV 1Y7I MSE B 108 UNP Q6RYA0 MET 108 MODIFIED RESIDUE SEQADV 1Y7I MSE B 149 UNP Q6RYA0 MET 149 MODIFIED RESIDUE SEQADV 1Y7I MSE B 183 UNP Q6RYA0 MET 183 MODIFIED RESIDUE SEQADV 1Y7I MSE B 239 UNP Q6RYA0 MET 239 MODIFIED RESIDUE SEQADV 1Y7I MSE B 241 UNP Q6RYA0 MET 241 MODIFIED RESIDUE SEQADV 1Y7I LEU B 261 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I GLU B 262 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS B 263 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS B 264 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS B 265 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS B 266 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS B 267 UNP Q6RYA0 EXPRESSION TAG SEQADV 1Y7I HIS B 268 UNP Q6RYA0 EXPRESSION TAG SEQRES 1 A 268 MET LYS GLU GLY LYS HIS PHE VAL LEU VAL HIS GLY ALA SEQRES 2 A 268 CYS HIS GLY GLY TRP SER TRP TYR LYS LEU LYS PRO LEU SEQRES 3 A 268 LEU GLU ALA ALA GLY HIS LYS VAL THR ALA LEU ASP LEU SEQRES 4 A 268 ALA ALA SER GLY THR ASP LEU ARG LYS ILE GLU GLU LEU SEQRES 5 A 268 ARG THR LEU TYR ASP TYR THR LEU PRO LEU MSE GLU LEU SEQRES 6 A 268 MSE GLU SER LEU SER ALA ASP GLU LYS VAL ILE LEU VAL SEQRES 7 A 268 GLY HIS SER LEU GLY GLY MSE ASN LEU GLY LEU ALA MSE SEQRES 8 A 268 GLU LYS TYR PRO GLN LYS ILE TYR ALA ALA VAL PHE LEU SEQRES 9 A 268 ALA ALA PHE MSE PRO ASP SER VAL HIS ASN SER SER PHE SEQRES 10 A 268 VAL LEU GLU GLN TYR ASN GLU ARG THR PRO ALA GLU ASN SEQRES 11 A 268 TRP LEU ASP THR GLN PHE LEU PRO TYR GLY SER PRO GLU SEQRES 12 A 268 GLU PRO LEU THR SER MSE PHE PHE GLY PRO LYS PHE LEU SEQRES 13 A 268 ALA HIS LYS LEU TYR GLN LEU CYS SER PRO GLU ASP LEU SEQRES 14 A 268 ALA LEU ALA SER SER LEU VAL ARG PRO SER SER LEU PHE SEQRES 15 A 268 MSE GLU ASP LEU SER LYS ALA LYS TYR PHE THR ASP GLU SEQRES 16 A 268 ARG PHE GLY SER VAL LYS ARG VAL TYR ILE VAL CYS THR SEQRES 17 A 268 GLU ASP LYS GLY ILE PRO GLU GLU PHE GLN ARG TRP GLN SEQRES 18 A 268 ILE ASP ASN ILE GLY VAL THR GLU ALA ILE GLU ILE LYS SEQRES 19 A 268 GLY ALA ASP HIS MSE ALA MSE LEU CYS GLU PRO GLN LYS SEQRES 20 A 268 LEU CYS ALA SER LEU LEU GLU ILE ALA HIS LYS TYR ASN SEQRES 21 A 268 LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 268 MET LYS GLU GLY LYS HIS PHE VAL LEU VAL HIS GLY ALA SEQRES 2 B 268 CYS HIS GLY GLY TRP SER TRP TYR LYS LEU LYS PRO LEU SEQRES 3 B 268 LEU GLU ALA ALA GLY HIS LYS VAL THR ALA LEU ASP LEU SEQRES 4 B 268 ALA ALA SER GLY THR ASP LEU ARG LYS ILE GLU GLU LEU SEQRES 5 B 268 ARG THR LEU TYR ASP TYR THR LEU PRO LEU MSE GLU LEU SEQRES 6 B 268 MSE GLU SER LEU SER ALA ASP GLU LYS VAL ILE LEU VAL SEQRES 7 B 268 GLY HIS SER LEU GLY GLY MSE ASN LEU GLY LEU ALA MSE SEQRES 8 B 268 GLU LYS TYR PRO GLN LYS ILE TYR ALA ALA VAL PHE LEU SEQRES 9 B 268 ALA ALA PHE MSE PRO ASP SER VAL HIS ASN SER SER PHE SEQRES 10 B 268 VAL LEU GLU GLN TYR ASN GLU ARG THR PRO ALA GLU ASN SEQRES 11 B 268 TRP LEU ASP THR GLN PHE LEU PRO TYR GLY SER PRO GLU SEQRES 12 B 268 GLU PRO LEU THR SER MSE PHE PHE GLY PRO LYS PHE LEU SEQRES 13 B 268 ALA HIS LYS LEU TYR GLN LEU CYS SER PRO GLU ASP LEU SEQRES 14 B 268 ALA LEU ALA SER SER LEU VAL ARG PRO SER SER LEU PHE SEQRES 15 B 268 MSE GLU ASP LEU SER LYS ALA LYS TYR PHE THR ASP GLU SEQRES 16 B 268 ARG PHE GLY SER VAL LYS ARG VAL TYR ILE VAL CYS THR SEQRES 17 B 268 GLU ASP LYS GLY ILE PRO GLU GLU PHE GLN ARG TRP GLN SEQRES 18 B 268 ILE ASP ASN ILE GLY VAL THR GLU ALA ILE GLU ILE LYS SEQRES 19 B 268 GLY ALA ASP HIS MSE ALA MSE LEU CYS GLU PRO GLN LYS SEQRES 20 B 268 LEU CYS ALA SER LEU LEU GLU ILE ALA HIS LYS TYR ASN SEQRES 21 B 268 LEU GLU HIS HIS HIS HIS HIS HIS MODRES 1Y7I MSE A 63 MET SELENOMETHIONINE MODRES 1Y7I MSE A 66 MET SELENOMETHIONINE MODRES 1Y7I MSE A 85 MET SELENOMETHIONINE MODRES 1Y7I MSE A 91 MET SELENOMETHIONINE MODRES 1Y7I MSE A 108 MET SELENOMETHIONINE MODRES 1Y7I MSE A 149 MET SELENOMETHIONINE MODRES 1Y7I MSE A 183 MET SELENOMETHIONINE MODRES 1Y7I MSE A 239 MET SELENOMETHIONINE MODRES 1Y7I MSE A 241 MET SELENOMETHIONINE MODRES 1Y7I MSE B 63 MET SELENOMETHIONINE MODRES 1Y7I MSE B 66 MET SELENOMETHIONINE MODRES 1Y7I MSE B 85 MET SELENOMETHIONINE MODRES 1Y7I MSE B 91 MET SELENOMETHIONINE MODRES 1Y7I MSE B 108 MET SELENOMETHIONINE MODRES 1Y7I MSE B 149 MET SELENOMETHIONINE MODRES 1Y7I MSE B 183 MET SELENOMETHIONINE MODRES 1Y7I MSE B 239 MET SELENOMETHIONINE MODRES 1Y7I MSE B 241 MET SELENOMETHIONINE HET MSE A 63 8 HET MSE A 66 8 HET MSE A 85 8 HET MSE A 91 8 HET MSE A 108 8 HET MSE A 149 8 HET MSE A 183 8 HET MSE A 239 8 HET MSE A 241 8 HET MSE B 63 8 HET MSE B 66 8 HET MSE B 85 8 HET MSE B 91 8 HET MSE B 108 8 HET MSE B 149 8 HET MSE B 183 8 HET MSE B 239 8 HET MSE B 241 8 HET SAL A 501 10 HET SAL A 502 10 HET SAL B 503 10 HETNAM MSE SELENOMETHIONINE HETNAM SAL 2-HYDROXYBENZOIC ACID HETSYN SAL SALICYLIC ACID FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 3 SAL 3(C7 H6 O3) FORMUL 6 HOH *461(H2 O) HELIX 1 1 GLY A 16 TYR A 21 5 6 HELIX 2 2 LYS A 22 ALA A 30 1 9 HELIX 3 3 LYS A 48 LEU A 52 5 5 HELIX 4 4 THR A 54 LEU A 69 1 16 HELIX 5 5 LEU A 82 TYR A 94 1 13 HELIX 6 6 SER A 116 THR A 126 1 11 HELIX 7 7 PRO A 127 LEU A 132 5 6 HELIX 8 8 GLY A 152 LEU A 160 1 9 HELIX 9 9 SER A 165 VAL A 176 1 12 HELIX 10 10 PHE A 182 SER A 187 1 6 HELIX 11 11 ARG A 196 VAL A 200 5 5 HELIX 12 12 PRO A 214 GLY A 226 1 13 HELIX 13 13 MSE A 239 GLU A 244 1 6 HELIX 14 14 GLU A 244 TYR A 259 1 16 HELIX 15 15 GLY B 16 TYR B 21 5 6 HELIX 16 16 LYS B 22 ALA B 30 1 9 HELIX 17 17 LYS B 48 LEU B 52 5 5 HELIX 18 18 THR B 54 LEU B 69 1 16 HELIX 19 19 LEU B 82 TYR B 94 1 13 HELIX 20 20 SER B 116 ARG B 125 1 10 HELIX 21 21 PRO B 127 LEU B 132 5 6 HELIX 22 22 GLY B 152 LEU B 160 1 9 HELIX 23 23 SER B 165 VAL B 176 1 12 HELIX 24 24 PHE B 182 LYS B 188 1 7 HELIX 25 25 ARG B 196 VAL B 200 5 5 HELIX 26 26 PRO B 214 ILE B 225 1 12 HELIX 27 27 MSE B 239 GLU B 244 1 6 HELIX 28 28 GLU B 244 HIS B 263 1 20 SHEET 1 A 6 LYS A 33 LEU A 37 0 SHEET 2 A 6 HIS A 6 VAL A 10 1 N PHE A 7 O LYS A 33 SHEET 3 A 6 VAL A 75 HIS A 80 1 O VAL A 78 N VAL A 10 SHEET 4 A 6 ILE A 98 LEU A 104 1 O VAL A 102 N LEU A 77 SHEET 5 A 6 ARG A 202 CYS A 207 1 O VAL A 203 N PHE A 103 SHEET 6 A 6 GLU A 229 ILE A 233 1 O ILE A 231 N VAL A 206 SHEET 1 B 2 GLN A 135 PRO A 138 0 SHEET 2 B 2 THR A 147 PHE A 150 -1 O SER A 148 N LEU A 137 SHEET 1 C 6 LYS B 33 ALA B 36 0 SHEET 2 C 6 HIS B 6 VAL B 10 1 N PHE B 7 O LYS B 33 SHEET 3 C 6 VAL B 75 HIS B 80 1 O VAL B 78 N VAL B 10 SHEET 4 C 6 ILE B 98 LEU B 104 1 O VAL B 102 N LEU B 77 SHEET 5 C 6 ARG B 202 CYS B 207 1 O VAL B 203 N PHE B 103 SHEET 6 C 6 GLU B 229 ILE B 233 1 O ILE B 231 N TYR B 204 SHEET 1 D 2 GLN B 135 PRO B 138 0 SHEET 2 D 2 THR B 147 PHE B 150 -1 O SER B 148 N LEU B 137 LINK C LEU A 62 N MSE A 63 1555 1555 1.33 LINK C MSE A 63 N GLU A 64 1555 1555 1.33 LINK C LEU A 65 N MSE A 66 1555 1555 1.33 LINK C MSE A 66 N GLU A 67 1555 1555 1.33 LINK C GLY A 84 N MSE A 85 1555 1555 1.33 LINK C MSE A 85 N ASN A 86 1555 1555 1.33 LINK C ALA A 90 N MSE A 91 1555 1555 1.33 LINK C MSE A 91 N GLU A 92 1555 1555 1.33 LINK C PHE A 107 N MSE A 108 1555 1555 1.33 LINK C MSE A 108 N PRO A 109 1555 1555 1.34 LINK C SER A 148 N MSE A 149 1555 1555 1.33 LINK C MSE A 149 N PHE A 150 1555 1555 1.33 LINK C PHE A 182 N MSE A 183 1555 1555 1.33 LINK C MSE A 183 N GLU A 184 1555 1555 1.33 LINK C HIS A 238 N MSE A 239 1555 1555 1.33 LINK C MSE A 239 N ALA A 240 1555 1555 1.33 LINK C ALA A 240 N MSE A 241 1555 1555 1.33 LINK C MSE A 241 N LEU A 242 1555 1555 1.33 LINK C LEU B 62 N MSE B 63 1555 1555 1.33 LINK C MSE B 63 N GLU B 64 1555 1555 1.33 LINK C LEU B 65 N MSE B 66 1555 1555 1.33 LINK C MSE B 66 N GLU B 67 1555 1555 1.33 LINK C GLY B 84 N MSE B 85 1555 1555 1.33 LINK C MSE B 85 N ASN B 86 1555 1555 1.33 LINK C ALA B 90 N MSE B 91 1555 1555 1.33 LINK C MSE B 91 N GLU B 92 1555 1555 1.33 LINK C PHE B 107 N MSE B 108 1555 1555 1.32 LINK C MSE B 108 N PRO B 109 1555 1555 1.34 LINK C SER B 148 N MSE B 149 1555 1555 1.33 LINK C MSE B 149 N PHE B 150 1555 1555 1.33 LINK C PHE B 182 N MSE B 183 1555 1555 1.33 LINK C MSE B 183 N GLU B 184 1555 1555 1.33 LINK C HIS B 238 N MSE B 239 1555 1555 1.33 LINK C MSE B 239 N ALA B 240 1555 1555 1.33 LINK C ALA B 240 N MSE B 241 1555 1555 1.33 LINK C MSE B 241 N LEU B 242 1555 1555 1.33 SITE 1 AC1 8 ALA A 13 SER A 81 LEU A 82 PHE A 107 SITE 2 AC1 8 TYR A 122 TRP A 131 PHE A 151 HIS A 238 SITE 1 AC2 7 LEU A 132 HIS A 158 LYS A 159 HOH A 562 SITE 2 AC2 7 LEU B 253 GLU B 254 HIS B 257 SITE 1 AC3 7 ALA B 13 SER B 81 LEU B 82 PHE B 107 SITE 2 AC3 7 TYR B 122 PHE B 151 HIS B 238 CRYST1 141.221 48.024 92.590 90.00 110.63 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007081 0.000000 0.002666 0.00000 SCALE2 0.000000 0.020823 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011540 0.00000